Why that matters: cortisol and GLP-1 effectiveness are inversely linked, and perimenopausal estrogen decline dysregulates the HPA axis, raising baseline cortisol and driving hormonal belly fat redistribution that keeps women stuck at a normal BMI with real metabolic dysfunction
I can't thank him enough." "Several years prior to seeing Dr
A study published in the Journal for Diabetes, Obesity, and Metabolism in April 2022, which examined changes in body weight and cardiometabolic risk factors upon the termination of the drug, found that after a year people had regained two-thirds of the weight they had lost
The dose ladder is a guide, not a race, and stepping back or holding is a normal, built-in part of the process
Clinical evidence also suggests potential advantages in wound healing
GLP-1 RAs were significantly associated with gastrointestinal AEs, and the association was further attributed to liraglutide, dulaglutide, and semaglutide